CIRCULATING CARDIAC BIOMARKERS IN HEART FAILURE: A CRITICAL LINK TO BIOMARKER-GUIDED THERAPY

CIRCULATING CARDIAC BIOMARKERS IN HEART FAILURE: A CRITICAL LINK TO BIOMARKER-GUIDED THERAPY

Current clinical guidelines for the diagnosis, treatment, and prevention of heart failure (HF) are the incorporated measure of biomarkers, predominantly natriuretic peptides (NP), cardiac troponins, soluble ST2 (sST2), and galectin-3, all of which serve as surrogate diagnostic and predictive factors...

Full description

Bibliographic Details
Main Author: Alexander E. Berezin
Format: Article
Language:English
Published: European Medical Journal 2019-10-01
Series:European Medical Journal Cardiology
Subjects:
heart failure
natriuretic peptides
cardiac biomarkers
cardiac troponins
soluble st2
galectin-3
nt-probnp
Online Access:https://www.emjreviews.com/cardiology/article/circulating-cardiac-biomarkers-in-heart-failure-a-critical-link-to-biomarker-guided-therapy/

Internet

https://www.emjreviews.com/cardiology/article/circulating-cardiac-biomarkers-in-heart-failure-a-critical-link-to-biomarker-guided-therapy/

Similar Items